(0.30%) 5 115.45 points
(0.31%) 38 357 points
(0.34%) 15 982 points
(-0.92%) $83.08
(5.77%) $2.03
(0.36%) $2 355.70
(0.46%) $27.66
(4.01%) $959.05
(-0.23%) $0.933
(-0.38%) $10.98
(-0.54%) $0.796
(1.69%) $93.43
Quarter results tomorrow
(bmo 2024-04-30)
Expected move: +/- 8.60%
Live Chart Being Loaded With Signals
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 147 486 |
平均出来高 | 88 559.00 |
時価総額 | 158.84M |
EPS | $0.0400 ( 2024-04-23 ) |
次の収益日 | ( $0.0600 ) 2024-04-30 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -45.75 |
ATR14 | $0.0450 (1.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-05 | Cote Jennifer | Buy | 35 800 | Common Stock |
2024-03-06 | Cote Jennifer | Sell | 9 920 | Common Stock |
2024-03-05 | Cote Jennifer | Buy | 35 800 | Common Stock |
2024-03-05 | Green James W | Buy | 214 797 | Common Stock |
2024-03-05 | Green James W | Buy | 214 797 | Common Stock |
INSIDER POWER |
---|
54.22 |
Last 100 transactions |
Buy: 2 506 245 | Sell: 1 191 931 |
ボリューム 相関
Harvard Bioscience Inc 相関 - 通貨/商品
Harvard Bioscience Inc 財務諸表
Annual | 2023 |
収益: | $112.25M |
総利益: | $60.87M (54.22 %) |
EPS: | $-0.0805 |
FY | 2023 |
収益: | $112.25M |
総利益: | $60.87M (54.22 %) |
EPS: | $-0.0805 |
FY | 2022 |
収益: | $113.34M |
総利益: | $60.82M (53.66 %) |
EPS: | $-0.230 |
FY | 2021 |
収益: | $33.06M |
総利益: | $19.56M (59.17 %) |
EPS: | $0.0236 |
Financial Reports:
No articles found.
Harvard Bioscience Inc
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tissue and organ-based lab research, including surgical products, infusion systems, and behavior research systems; and spectrophotometers, microplate readers, amino acid analyzers, gel electrophoresis equipment, and electroporation and electrofusion instruments. It also engages in the development and manufacture of precision scientific measuring instrumentation and equipment, which cover data acquisition systems with custom amplifier configurations for cellular analysis, micro electrode array solutions for in vivo recordings, and vitro-systems for extracellular recordings; and offers preclinical products. The company markets its products through sales organizations, websites, catalogs, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories, as well as to contract research organizations, academic labs, and government researchers. It primarily sells its products under Harvard Apparatus, DSI, Ponemah, Buxco, Biochrom, BTX, and MCS brand names. The company was founded in 1901 and is headquartered in Holliston, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。